key: cord-0854061-qr3duhs4 authors: Luo, Ding; Tong, Jian-Bo; Zhang, Xing; Xiao, Xue-Chun; Bian, Shuai title: Computational strategies towards developing novel SARS-CoV-2 M(pro) inhibitors against COVID-19 date: 2021-08-28 journal: J Mol Struct DOI: 10.1016/j.molstruc.2021.131378 sha: 72f90b3b016ede73f4b3f46d4081dd69fd613d8f doc_id: 854061 cord_uid: qr3duhs4 The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains to be a serious threat due to the lack of a specific therapeutic agent. Computational methods are particularly suitable for rapidly fight against SARS-CoV-2. This present research aims to systematically explore the interaction mechanism of a series of novel bicycloproline-containing SARS-CoV-2 M(pro) inhibitors through integrated computational approaches. We designed six structurally modified novel SARS-CoV-2 M(pro) inhibitors based on the QSAR study. The four designed compounds with higher docking scores were further explored through molecular docking, molecular dynamics (MD) simulations, free energy calculations, and residual energy contributions estimated by the MM-PBSA approach, with comparison to compound 23(PDB entry 7D3I). This research not only provides robust QSAR models as valuable screening tools for the development of anti-COVID-19 drugs, but also proposes the newly designed SARS-CoV-2 M(pro) inhibitors with nanomolar activities that can be potentially used for further characterization to treat SARS-CoV-2 virus. The unprecedented coronavirus disease (COVID-19) that spreads rapidly around the globe has led to a severe health crisis [1] . The COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which shares approximately 82% sequence identity with SARS-CoV [2] . The surprising speed of SARS-CoV-2 is attributed to a large number of mild or asymptomatic infections [3] . Remdesivir, which demonstrates pan-coronavirus suppression potential, and has obtained FDA approval for treating COVID-19 [4, 5] . More data is still needed to prove its effectiveness. Although the strategy of using other existing drugs for the treatment of this disease has been exploited, effective treatment options are still limited [6, 7] . It is imminent to provide effective and safe antiviral drugs against SARS-CoV-2. For coronavirus, the cleavage of two polyproteins (pp1a/pp1ab) into a single nonstructural protein is critical for the assembly of the viral replication-transcription [8] , which is processed by main protease (M pro , 3CL pro) and papain-like protease (PLpro), thus are essential in the normal expression of SARS-CoV-2 virus [9] . Especially, M pro was identified as an attractive target for antiviral drug design on account of its vital role and no human homolog [10, 11] . Compared with complex drug synthesis process, the computational approaches such as QSAR (quantitative structure-activity relationship), molecular docking, pharmacophore modeling [12] [13] [14] , etc., are effective for finding new drug targets and reusing existing drugs [15] , in the development of the anti-SARS-CoV-2 drugs. Furthermore, despite the SARS-CoV and SARS-CoV-2 have approximately 82% sequence similarity of M pro , most of the computational strategy is to leverage drugs and biomolecules previously reported to have activity against related coronaviruses [16] [17] [18] [19] [20] , and few reports on data specific to SARS-CoV-2 M pro . In Amin et al. [21] performed the first structure-activity relationship analysis on the structure-activity data of recently reported diverse SARS-CoV-2 M pro inhibitors to understand the structural requirements for higher inhibitory activity. However, the activity deviation between different data sets is not considered and it is unavoidable. Herein, we chose a series of 32 new SARS-CoV-2 M pro inhibitors synthesized by Qiao et.al [22] to investigate the structural requirements of such inhibitors against SARS-CoV-2 M pro using computational methods. Those SARS-CoV-2 M pro inhibitors were based on the reported crystal structures of SARS-CoV-2 M pro and cocrystal structures of SARS-CoV-2 M pro in complex with the approved antivirals against hepatitis C virus infection, boceprevir (PDB entry 7COM) and telaprevir (PDB entry 7C7P), and two compounds were tested for antiviral activity in mice. The cocrystal structure of M pro in complex with the synthesized compound 23, which is one of the most potent compounds, was released to revealed its interaction modes (PDB entry 7D3I). This provides new information for the rational design of new type SARS-CoV-2 M pro inhibitors based on its good inhibitory effect and binding mode revealed in detail. Molecular modeling in combination to molecular dynamics simulation has been widely used in computer-aided drug design [23, 24] . QSAR is one of the effective methods for predicting the activity of compounds when data and appropriate experimental facilities are lacking [25] . Whereas molecular docking is a very fast and efficient tool for predicting how a small molecule will have a conformational geometry on the active site of the target protein [26] . These computational methods are particularly suitable for rapidly fighting against SARS-CoV-2. Therefore, the present study was conducted using QSAR coupled with molecular docking approach, MD simulation, and free binding energy MM/PBSA analysis, to investigate the structural requirements of SARS-CoV-2 M pro inhibitors and to design novel compounds that can be helpful against SARS-CoV-2 infection. The outcomes could provide insightful direction to design more active peptide-type compounds which can be further synthesized and screened for their potential utilization in the SARS-CoV-2 M pro inhibition. The experimental activity data to perform the molecular modeling of 32 new bicycloproline-containing M pro inhibitors derived from either boceprevir or telaprevir were taken from the recent literature [22] . The corresponding half-maximal inhibitory concentration (IC50) nM value was converted into pIC50 (-log IC50) value, as the dependent variable in the analysis of QSAR models. 32 compounds were divided into a training set composed of 24 compounds (75%) for establishing QSAR models and a test set composed of 8 compounds (25%) for model validation (Fig. 1) . The test and training sets were chosen in such a way that the chemical diversity and a good range of activity were maintained throughout both sets. Outliers are generally removed as they result in ambiguity in statistical models. The range of the biological activities spans 1.99 log units, from 6.13 to 8.12. The structures of all compounds and their activity values (pIC50) are listed in Table 1 . The 3D conformation of each compound was generated by the SketchTool module in the SYBYL software package. Partial atomic charges were calculated by Gasteiger- The alignment was carried out by the distill module implemented in SYBYL 2.0 in which a common core scaffold was identified among all the 32 molecules and was shown in Fig. 2(a) . The lowest conformation of compound 23 was selected as a template because the most active compound of the data set. The remaining compounds of the dataset were aligned on this highest active compound based upon the common substructure similarity ( Fig. 2(b) ). The CoMFA (Comparative molecular field analysis) and CoMSIA (Comparative molecular similarity index analysis) studies have been performed based on the molecular alignment using SYBYL software to explore the contributions of diverse interactions. CoMFA and CoMSIA fields were calculated for each compound in a dataset at every grid point using an sp 3 -hybridized carbon probe with a charge of +1.0 [28] . The stereo field action is calculated by Lennard-Jones Eq. (1), and the electrostatic field calculation adopts the Coulomb Eq. (2). Where represents the space potential energy of the compound, and represent the corresponding atomic van der Waals radius constants, n is the total number of atoms in the molecule, is the electrostatic field energy of the compound, is the net charge of the atom calculated by the Gasteiger-Huckel method, is the probe charge of the atom, and D is the dielectric constant. In the CoMSIA analysis, descriptors such as spatial, electrostatic, hydrophobic, hydrogen bond donor, and acceptor fields were obtained [29] . Compared to CoMFA, CoMSIA uses a Gaussian function and the similarity index of the Gaussian distribution to avoid mutations in the grid-based probe-atom interaction [30] . The Topomer CoMFA modeling is a combination of the spatial, electrostatic, and topological properties of molecules. Topomer CoMFA modeling eliminates the steps that affect the prediction results, such as molecular overlap, and defines the activity value of the compound as the contribution value represented by each fragment through molecule cutting [31] . Topomer is similar to CoMFA in creating a spatial contour map produced by a stereocenter and position, with the Tripos force field method of +1 atomic charge. Importantly, the robustness of the generated QSAR model depends on the appropriate cutting method. Herein, we chose the highest M pro inhibitors (compound 23) as the template for cutting. According to the structural characteristics of the inhibitors, the 32 compounds are divided into fragments by the same cutting method (Fig. S1 ). HQSAR (Holographic QSAR) converts the molecular structure into characteristic molecular fingerprints according to the types of molecular fragments and marks with numbers (53-401) [32] . These marked numbers are used as QSAR descriptors to establish the corresponding structure-activity relationship to predict the biological activity of the compounds. Different fragment descriptors that including Atoms (A), Bonds(B), Connections (C), Chirality (Ch), Hydrogen atoms(H), Donor and Acceptor (DA) were utilized in combination with adjusted dimensions and holographic lengths to obtain an HQSAR model with good predictive ability. The Partial least square method [33] is applied to generate QSAR models as an extension of multiple regression analysis. The generated CoMFA, CoMSIA, Topomer CoMFA, and HQSAR descriptors were set as independent variables and M pro inhibitory activity (pIC50) as the dependent variable. Cross-validation correlation coefficient 2 (Eq. (3)) and the optimal number of components (ONC) was executed by Leave-oneout (LOO) cross-validation analysis. In order to further verify the model internally, the non-cross-validated and bootstrap PLS analysis was performed using ONC obtained from the LOO method. The non-cross-validation correlation coefficient ( 2 ) (Eq. (4)) value, the standard error estimate (SEE), the F-test value (F), and contributions of each field were determined to better evaluate the accuracy and robustness of the developed models. Usually, high 2 and 2 ( 2 > 0.5, 2 > 0.6) values are considered to be the proof that the high predictive ability of the QSAR model is in line with expectations [34] . whereas, ̂ and are predicted, observed activity values, and ̅ and ̂ are observed and predicted mean activity values of the training set, respectively. Validation of the QSAR model is essential for understanding the predictive power of the established QSAR models. 2 represents the correlation between the experimental and predicted activities of the test set; k and k' represent the regression slope of the experimental activity and the predicted activity or the regression slope of the predicted activity and the observed activity through the origin. 2 and 0 2 represent the correlation coefficients between the observed and predicted activity of the test set without intercept. We have implemented molecular docking studies to explore the interaction pattern of compounds with their relevant enzyme (M pro ). Choosing an appropriate docking method is a crucial factor in determining whether the molecular docking simulation is realistic. We attempt to select the most suitable one from the following docking protocols to evaluate the binding mode between protein and ligand: (1) Surflex-Dock: Surflex-Dock is a Protomol-based method with fast and accurate molecular docking mean, which uses a unique empirical scoring function and a patented search engine (based on the molecular similarity search engine) to dock ligand in the binding site of the target protein [38] . (2) Autodock 4.2: AutoDock4.2 relies on many approximate values to predict the conformation and binding free energy during docking simulation. Ligands are considered to be flexible. But different from traditional molecular mechanics methods, only torsion degrees of freedom is discussed to keep the bond angle and bond length constant [39] . The empirical free energy force field is based on a molecular mechanics force field, which includes typical terms for dispersion/repulsion, hydrogen bonding, electrostatics, desolvation, and torsional entropy. (3) Autodock Vina: Vina improves the average accuracy of combined mode prediction, and speeds up the search by using a simpler scoring function [40] . Vina's scoring function is completely empirical, including Gaussian spatial interaction, repulsion, hydrogen bonding, hydrophobic, and torsion terms. Furthermore, Vina has parallel calculation functions and is very easy to use [41] . The energies of the prepared proteins and ligands are minimized and unnecessary water molecules are removed. Under the Kollman united force field with the nonbonding cut-off value set to 8.0 and the dielectric constant set to 1.0, the protein performs 1000 energy minimization iterations according to the gradient of the Powell method. The grids were chosen to be sufficiently large to include not only the active site but also a significant portion of the surrounding surface at receptor protein with grid points 60 × 60 × 60, along with a grid spacing of 0.375 Å. The MD simulation was performed in Gromacs 5.15 [42] with CHARMM36 (Feb-2021) force field [43] to investigate the interaction between the receptor and ligand, and the time step is set to 2 fs. The topology files of the protein and ligand were obtained by executing the pdb2gmx command and employing the CHARMM General Force Field [44] , respectively. The system is immersed in a periodic boundary condition (PBC) 12-sided box composed of Tip3p water model, followed by ionization and neutralization in Na + and Clions. The energy minimization was performed for 50,000 steps using the steepest descent algorithm. Two equilibration phases for NVT and NPT are in sequence to balance the temperature of 300 K and the atmospheric pressure of 1 atm. The simulation of each selected complex was performed for 50 ns. Molecular dynamics trajectories were analyzed using tools in the GROMACS suite， including root mean square deviation (RMSD), root mean square fluctuation (RMSF), solvent-accessible surface area (SASA), number of hydrogen bonds, and Radius of gyration (Rg). PCA/essential dynamics statistical tools are used to identify similarities and differences in specific data sets, and to detect patterns in specific data sets. The principal component analysis (PCA) method in Gromacs was utilized to analyze the eigenvectors and eigenvalues to obtain the projection of the first two principal components (PC1 and PC2) [45] . The trajectories on eigenvectors were projected by gmx anaeig module, and covariance matrix was constructed by Gmx covar module. The molecular mechanics/Poisson-Boltzmann surface area (MM-PBSA) method was performed to estimate the binding free energy (∆ bind ) of the SARS-CoV-2 M pro -ligand complex, which is a widely used endpoint method in free energy calculations [46, 47] . The binding free energies of the complex in liquid/solution were determined with the g_mmpbsa tool [48] by Eq. (17): = ∆ MM + ∆ polar + ∆ SASA − ∆S = ∆ vdw + ∆ elec + ∆ polar + ∆ SASA − ∆S ∆ bind represents the net free binding energy, and ∆ MM indicates molecular mechanics potential energy, which consists of van der Waals (∆ vdw ) and electrostatic energy (∆ elec ). ∆ polar and ∆ SASA indicate polar solvation and nonpolar solvation contributions, respectively. TΔS refers to conformational entropy contribution at temperature T. The contribution of TΔS term to the binding energy can be ignored when calculating relative binding affinity energy [49] . To further confirm the key residues involved in the binding modes, the binding free energy decomposition was calculated, which utilized the python script MmPbSaDecomp.py (available at http://rashmikumari.github.io/g_mmpbsa) after the calculation of every term of binding energy contribution. The amino acid residues whose binding energy contribution is less than -2 KJ/mol and greater than 2 KJ/mol are selected to reveal their favorable and unfavorable contributions in the simulation process. In silico ADMET prediction ADMET (drug absorption, distribution, metabolism, excretion, and toxicity) pharmacokinetic property is a very essential means in contemporary drug design and drug screening. The early ADMET property evaluation can effectively solve the problem of species differences, significantly improve the success rate of drug development, and reduce drug development costs, drug toxicity, and side effects, The ADMET properties of newly designed compounds were predicted using the Online web server ADMETlab2.0 [50] , followed SwissADME online tool [51] for the prediction of their drug-likeness and synthetic difficulty. The statistical values of CoMFA and Topomer CoMFA models constructed by steric and electrostatic descriptors are listed in Table 2 Eighteen HQSAR models were established by combining different fragment parameter descriptors (Table S2) . The optimal HQSAR model is obtained while combining fragment descriptors Atoms (A), Bonds (B), Connections (C), Chirality (Ch), and followed the default fragment lengths 4-7, which gives 2 to be 0.827 and 2 0.945, with a hologram length of 61 and a component of 4. Moreover, the best HQSAR model 9 was selected for further improvement of the quality. For this purpose, the fragment sizes of 1-10 were explored, with the higher 2 as a chosen criterion. It was found in Table S3 that the best model represents the results the same as HQSAR model 9, which achieved default fragment lengths of 4-7. High value of 2 does not imply that the model has high predictive power, and the independent test set was chosen for further evaluation of the QSAR model to ensure its robustness and stability. Before using the test set as the external verification, it is crucial to eliminate possible systematic errors. The experimental and predicted pIC50 with residual values of CoMFA, CoMSIA, Topomer CoMFA, and HQSAR are shown in Table 3 , and graphically depicted in Fig. 3 . Compound 24 has large residual values in all QSAR models that are reflected in both Table 3 In addition, The Y-randomization test was performed on the QSAR models to evaluate the robustness of the model and to avoid accidental correlations that may appear [52] . 10 random trials were run for the PLS model (Table S4) is reliable [53] . The robust and predictable QSAR model that can be used to predict new compounds should be followed by an applicability domain [54] . The applicability domain test was performed using the standardized method developed by Roy (http://dtclab.webs.com/software-tools). Regarding the applicability domain QSAR models, there is no compound located outside the AD for the QSAR models, which is consistent with the characteristics of this type of SARS-CoV-2 inhibitor. No compound has a divergence from other compounds. The contour map of the CoMFA/Topomer CoMFA/CoMSIA model is a tool to explain the important structural aspects through the favorable and unfavorable regions in different fields. In steric contour maps, the green contours indicate that the large substituent has higher activity, while yellow contours stand for the large substituent with lower activity. In electrostatic contour maps, red contours represent electronegative charge favored region and blue contour map represents the electropositive charge favored region. Regarding the CoMFA steric maps in Fig. 4(a) , big green contours covered the 2 nd and 3 rd positions at a phenyl moiety of compound 23 , which suggests that the bulky group was favorable in the region. This agrees with the fact that the activity of compound 19 (pIC50 = 6.293) is higher than compound 18 (pIC50 = 6.918) and compound 20 (pIC50 = 6.380). The green contours that appear at the introduction of the phenyl ring indicate that bulky group favorable in the region, such as compound 2 with O atom has higher activity than compound 1 with a C atom. Furthermore, a big yellow contour around the R1 substituent suggests that the less-bulky group here is beneficial to increase the inhibitory activity, such as the activity of compound 21 (pIC50 = 8.12) is higher than compound 3 (pIC50 = 7.78). (Table 3) . The CoMSIA steric contour maps were both similar to the CoMFA/Topomer CoMFA contour maps discussed above ( Fig. 5(a) ). Thus, only hydrophobic fields of CoMSIA were analyzed. In the hydrophobic contour map (Fig. 5(b) ), the cyan contours show favorable hydrophobic regions, while magenta contours represent unfavorable hydrophobic regions. For the hydrophobic map, the cyan favorable region could be found around 2 nd and 3 rd positions at a phenyl ring of R2 substitutes, which indicates that the addition of hydrophobic substituents in this region would lead to an increase in the activity. For instance, compound 6 (pIC50 = 7.84) with a -OCH3 substituents at 3 rd position of phenyl has higher activity than compound 8 (pIC50 = 7.43) with a less hydrophobic substituent (3 rd of phenyl = -F). The magenta unfavorable region could be found around the 4 th position at a phenyl ring of R2 substitutes, which indicates that the addition of hydrophobic substituents in this region would lead to decreased activity. For instance, the activity of compound 21 (4 th of phenyl = -H) is higher than compound 22 (4 th of phenyl = -F). Also, the magenta unfavorable region could be found at R1 substitutes, which reveals that R1 substitutes should be less hydrophobic substituents. This is further verified by the Topomer CoMFA contribution results. is essential for antiviral activity [22, 55] . In addition, certain interactions between the F atom at the benzyl ring of the R2 substituent and the amino acid residues Pro168 and Thr190 were observed. Moreover, the direct connection between the piperidine group and the amide group hinders the formation of a hydrogen bond. This may enhance the strong interactions on the R2 substituents and would lead to a more stable bonding mode. The interpretation of QSAR models provide us more flexible design tips for Table 5 represents the structures of designed compounds N1-N6 along with their predicted pIC50 values for SARS-CoV-2 M pro . All the newly designed inhibitors showed high predicted pIC50 values compared to compound 23. This suggests that these compounds are potential candidates as SARS-CoV-2 inhibitors. However, these compounds still need to be synthesized combined with in vitro and in vivo evaluation to confirm their efficacy in inhibiting SARS-CoV-2 M pro . Table 6 Taken together, the R1 substituents in the active site mainly form on the hydrophobic interaction with amino acid residue Leu27, Met49 to maintain a stable conformation, and the R2 substituents in the active site rely on the hydrophobic interaction with the amino acid residues Met165, Leu167, Pro168, and Thr190, and on the hydrogen bond with amino acid residue Gln192 to maintain a stable conformation. Serval stable hydrogen bonds can be formed at aligned backbone position with amino acid residues Phe140, Gly143, Cys145, His164, and Glu166. The radius of gyration of M pro -N3 has relatively obvious fluctuations, then tends to balance around 30 ns ( Fig. 10(b) ). The Rg results show that all M pro -ligand systems reach a level of compactness, which indicates that each compound can interact with SARS-CoV-2 M pro without affecting its structural folding in the dynamic environment. It is known that a complex that occupies less phase space and shows a stable cluster would have higher stability, while a complex that occupies more space and shows an unstable cluster indicates worse stability. The M pro -N3 and M pro -N5 systems occupy more space, followed by the M pro -N6 system, and show less stable clusters as compared to other complexes. The 7D3I and M pro -N4 complexes occupy less phase space as compared to the other complexes, and show a stable cluster. These observations suggest the stability of newly designed compounds is similar with 7D3I, and ultimately can restrict the protein essential motions required for exhibiting enzymatic activity, which is also supported by RMSD, RMSF, SASA, Rg, protein-ligand interaction profiling, and the substantial docking scores ( Table 6 , Fig. 9, Fig. 10 ). The binding free energies of the five complexes were calculated using the MM-PBSA approach and the results are summarized in Table 7 The amino acid residues involved in the interactions between SARS-CoV-2 M pro and ligands are observed by monitoring the binding free energy contribution (Fig. 12) Furthermore, the amino acid residues of Met49, His164 and Met165 contribute more than others to the five complexes, which indicates their significant roles in ligand binding in five systems. Those findings confirm the docking results (Table 6) . Interestingly, the important amino acid residue Cys145 seems not to have a higher binding free energy contribution in the simulation process, and the binding affinity between ligand and SARS-CoV-2 M pro is more dependent on hydrophobic interactions. Fig. 12 : Plots of binding free energy decomposition for the five complex systems. The bioavailability (absorption, distribution, metabolism, and excretion) of newly designed compounds were estimated to elucidate the drug-likeness of strong binders, which is an important criterion for approving any compound for clinical trials. ADMET scores for newly designed compounds are listed in indicates that N3 is not cleared from the body more slowly. Finally, the newly designed compounds were predicted to be AMES toxic. Table S6 . All designed compounds are acceptable considering the Lipinski Rule, Pfizer Rule, Golden Triangle and are rejected by GSK Rule. This is because the molecular weights of newly designed compounds, including compounds in the data set, are higher than 400 g/mol, which violates the GSK Rule. But the molecular weights of Remdesivir, which has been approved by the FDA for treating COVID-19, are also higher than 400 g/mol. Therefore, the GSK Rule is not an absolute condition for determining the drug-likeness properties. Furthermore, all the newly designed compounds are predicted to have convenient synthesis accessibility (4.37-4.71). The quick and efficient development of active antiviral agents for therapeutic use is exceptionally challenging. In the current study, a series of bicycloproline-containing SARS-CoV-2 M pro inhibitors are used for molecular modeling. The robust QSAR models were established to predict the enzyme inhibition of SARS-CoV-2 M pro , with structural modification information to design six potent SARS-CoV-2 M pro inhibitors. The Per-residue energy decomposition analysis demonstrates binding affinity between the ligands and SARS-CoV-2 M pro is more dependent on hydrophobic interactions. Furthermore, all newly designed compounds are confirmed to have good ADMET properties through the webserver prediction. Also, compared to recent efforts to identify promising attributes for previous coronavirus inhibitors, the present study deals with the existing SARS-CoV-2 M pro inhibitors and avoids activity test deviation between different data sets [21] . Taken together, the results from this study provide a reference for the further rational design of novel SARS-CoV-2 M pro inhibitors with high potency. The authors declare that they have no conflict of interest Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir Conservation of substrate specificities among coronavirus main proteases Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2 QSAR Modeling of SARS-CoV Mpro Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS-CoV-2 Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 Silico Modeling of Small Molecule Carboxamides as Inhibitors of SARS-CoV 3CL Protease: An Approach Towards Combating COVID-19 Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors In silico modeling for quick prediction of inhibitory activity against 3CLpro enzyme in SARS CoV diseases A computational approach for designing novel SARS-CoV-2 Mpro inhibitors: combined QSAR, molecular docking, and molecular dynamics simulation techniques Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations First structureactivity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery Mpro inhibitors with antiviral activity in a transgenic mouse model Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach Cloud 3D-QSAR: a web tool for the development of quantitative structure-activity relationship models in drug discovery Potential tripeptides against the tyrosine kinase domain of human epidermal growth factor receptor (HER) 2 through computational and kinase assay approaches Comprehensive Evaluation of Fourteen Docking Programs on Protein-Peptide Complexes Design of novel SHP2 inhibitors using Topomer CoMFA, HQSAR analysis, and molecular docking Structural insights for rational design of new PIM-1 kinase inhibitors based on 3,5-disubstituted indole derivatives: An integrative computational approach Structure-Activity Relationships Based on 3D-QSAR CoMFA/CoMSIA and Design of Aryloxypropanol-Amine Agonists with Selectivity for the Human β3-Adrenergic Receptor and Anti-Obesity and Anti-Diabetic Profiles 3D-QSAR in Drug Design -A Review Structural investigation of tetrahydropteridin analogues as selective PLK1 inhibitors for treating cancer through combined QSAR techniques, molecular docking, and molecular dynamics simulations HQSAR and random forest-based QSAR models for anti-T. vaginalis activities of nitroimidazoles derivatives QSAR and QSPR Model Interpretation Using Partial Least Squares (PLS) Analysis A Historical Excursus on the Statistical Validation Parameters for QSAR Models: A Clarification Concerning Metrics and Terminology Be aware of error measures. Further studies on validation of predictive QSAR models Comments on the Definition of the Q2 Parameter for QSAR Validation Beware of q2! Molecular modelling studies of tricyclic triazinone analogues as potential PKC-θ inhibitors through combined QSAR, molecular docking and molecular dynamics simulations techniques Virtual screening with AutoDock: theory and practice Autodock Vina Adopts More Accurate Binding Poses but Autodock4 Forms Better Binding Affinity AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading GROMACS: Fast, flexible, and free CHARMM: The biomolecular simulation program Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing Molecular dynamics simulation study on Thermotoga maritima EngA: GTP/GDP bound state of the second G-domain influences the domain-domain interface interactions End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules Antiprotozoal QSAR modelling for trypanosomiasis (Chagas disease) based on thiosemicarbazone and thiazole derivatives Prediction of aquatic toxicity of chemical mixtures by the QSAR approach using 2D structural descriptors silico drug discovery of Acetylcholinesterase and Butyrylcholinesterase enzymes inhibitors based on Quantitative Structure-Activity Relationship (QSAR) and druglikeness evaluation Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease The authors would like to sincerely thank Prof. Ran Fang at Shaanxi University of Science and Technology for providing high-performance computer for research facilities.